Insider · CIK 0001577014

Rhodes Jason P

CIK 0001577014 Name as filed on the most recent filing

Filed as Rhodes Jason P (34)

240 transaction lines · from 34 filings · filed 2014-01-06 to 2026-08-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

240 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 327,578, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 268,095, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 113,289, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 79,174, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 74,180, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 67,165, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 28,378, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 27,373, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 25,634, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 6,843, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 6,419, disposed Open Form 4 filing 0001209191-20-062624
2020-12-09 S, Open-market sale Replimune Group, Inc.REPL 4,647, disposed Open Form 4 filing 0001209191-20-062624
2020-12-08 S, Open-market sale Replimune Group, Inc.REPL 6 lines 5,056,591, disposed Open Form 4 filing 0001209191-20-062624
2020-12-07 S, Open-market sale Replimune Group, Inc.REPL 9 lines 3,120,459, disposed Open Form 4 filing 0001209191-20-062624
2019-11-18 P, Open-market purchase Replimune Group, Inc.REPL 14,971,000, acquired Open Form 4 filing 0001209191-19-057475
2014-09-02 S, Open-market sale Epizyme, Inc.EPZM 2 lines 1,004,163, disposed Open Form 4 filing 0001209191-14-055974
2014-08-04 S, Open-market sale Epizyme, Inc.EPZM 2 lines 892,324, disposed Open Form 4 filing 0001209191-14-050706
2014-07-07 S, Open-market sale Epizyme, Inc.EPZM 2 lines 982,161, disposed Open Form 4 filing 0001209191-14-046579
2014-06-02 S, Open-market sale Epizyme, Inc.EPZM 2 lines 665,870, disposed Open Form 4 filing 0001209191-14-039098
2014-05-05 S, Open-market sale Epizyme, Inc.EPZM 645,840, disposed Open Form 4 filing 0001209191-14-031300
2014-04-07 S, Open-market sale Epizyme, Inc.EPZM 501,190, disposed Open Form 4 filing 0001209191-14-026496
2014-02-10 S, Open-market sale Epizyme, Inc.EPZM 1,462,500, disposed Open Form 4 filing 0001209191-14-009941
2014-01-06 S, Open-market sale Epizyme, Inc.EPZM 201,874, disposed Open Form 4 filing 0001209191-14-002100

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 238
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Rhodes Jason P, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001577014

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.